ZEAL ONCOLOGY Trademark

Trademark Overview

On Thursday, April 25, 2024, a trademark application was filed for ZEAL ONCOLOGY with the United States Patent and Trademark Office. The USPTO has given the ZEAL ONCOLOGY trademark a serial number of 98519084. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, February 11, 2025. This trademark is owned by Zeal Oncology. The ZEAL ONCOLOGY trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific research consulting in the field of oncology
zeal oncology

General Information

Serial Number98519084
Word MarkZEAL ONCOLOGY
Filing DateThursday, April 25, 2024
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, February 11, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 17, 2024

Trademark Statements

NOT AVAILABLE"ONCOLOGY"
Goods and ServicesScientific research consulting in the field of oncology

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, April 25, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameZeal Oncology
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCarlsbad, CA 92010
Party NameZeal Oncology
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCarlsbad, CA 92010

Trademark Events

Event DateEvent Description
Thursday, April 25, 2024NEW APPLICATION ENTERED
Thursday, October 17, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, November 9, 2024ASSIGNED TO EXAMINER
Friday, November 15, 2024NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Friday, November 15, 2024COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Friday, November 15, 2024EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Friday, November 15, 2024EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Monday, November 18, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 18, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 18, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 19, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 11, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 17, 2024PUBLISHED FOR OPPOSITION
Tuesday, December 17, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 1, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 1, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, April 1, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 1, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, April 1, 2025TEAS STATEMENT OF USE RECEIVED
Tuesday, February 11, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Related Keywords

oncology zeal field consulting research scientific